Search results

Scientific Publication

Case Study—Nanosuspension Formulation to Maximize Potency for Preclinical Studies

Sep 6, 2024
- Manufacturing and Analytical Services
- Preclinical Research
Blog

Inside The Altascientist: How to Achieve Optimal Preclinical Formulation and Drug Product Manufacture

Jul 18, 2024

Issue 38 of The Altascientist explores the key considerations for successful formulation development and manufacture for safety assessment, alongside examining the strategies Altasciences employs to support you in planning your program. Read or listen!
- Preclinical Research
- Manufacturing and Analytical Services
Scientific Publication

Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs

Jun 20, 2024
- Clinical Trials
Scientific Publication

Pragmatic Considerations for the Application of Physical Withdrawal Assessments in Patient Studies

Jun 20, 2024
- Clinical Trials
Blog

Five Promising Treatment Areas in Early-Phase Drug Development in 2024

Apr 17, 2024

Explore emerging areas of drugs from psychedelics and gene therapy, oligonucleotides to GLP-1RA for metabolic disorders.
- Science and Health
- About Altasciences
ISSUE NO. 39 — Considerations for Nonclinical Dermal Studies: Advancing to Phase I

Apr 11, 2024
- Preclinical Research
ISSUE NO. 38 — Achieving Optimal Preclinical Formulation and Drug Product Manufacture

Mar 26, 2024
- Preclinical Research
- Manufacturing and Analytical Services